← Eichor
Study identifier: NCT07456111 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy

Condition: Colonic Polyp · Sedation Complication  ·  Sponsor: Clinical Hospital Centre Zagreb

PhasePhase 4
Planned participants90
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

The goal of this prospective, randomized, controlled study is to compare remimazolam besilat/sufentanyl and propofol/sufentanyl in patients during colonoscopic polypectomies procedures. Patients undergoing colonoscopic polypectomies in procedural sedation using remimazolam besylate/sufentanyl are circulatory and respiratory as or more stable when compared with propofol/sufentanyl sedation.

This description comes directly from the study's public registry record.

Talk to the study team

Željko Drvar, MD, PhD  ·  003851 2388 888  ·  zeljko.drvar@kbc-zagreb.hr

Always discuss trial participation with your own doctor first.

Locations (1)

UHC ZagrebZagreb, CroatiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07456111